Skip to main content
PMC home page
The Journal of Hygiene logoLink to The Journal of Hygiene
. 1984 Oct;93(2):355–363. doi: 10.1017/s0022172400064913

Vaccination against Klebsiella aerogenes.

E A Roe, R J Jones
PMCID: PMC2129420  PMID: 6389699

Abstract

Klebsiella vaccine was prepared from strains of Klebsiella aerogenes with capsular types K1, K36, K44 and K Cross (a type which cross-reacts in vitro with sera from many klebsiella capsular types). The vaccine was extracted by dialysis and ultrafiltration from capsular material released during growth of the bacteria in a five-day batch culture. Mice given one dose of vaccine from K1a (1.0 microgram/mouse) survived lethal intraperitoneal challenge of 11/11 homologous klebsiella strains four days after vaccination; 14 days after vaccination protection against the same challenge strains had declined to 5/11 strains. Vaccines from K1a, b, c, K36, K44 and K Cross induced homologous protection and protected mice against different ranges of heterologous klebsiella capsular types. The protective response of the mice was greatly enhanced by administering three doses of the vaccines. Vaccines from K1, K36, K44 and K Cross protected mice against 14/20, 11/20, 10/20 and 9/20 homologous and heterologous klebsiella challenge strains respectively. None of the klebsiella vaccines was toxic for mice at the immunizing dose (1.0 microgram/mouse). Vaccine from K36 was the most lethal, killing mice at 10(3) immunizing doses. The least toxic vaccine was from K44, which killed mice at 10(4) immunizing doses.

Full text

PDF
355

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander J. W., Fisher M. W., MacMillan B. G., Altemeier W. A. Prevention of invasive pseudomonas infection in burns with a new vaccine. Arch Surg. 1969 Aug;99(2):249–256. doi: 10.1001/archsurg.1969.01340140121018. [DOI] [PubMed] [Google Scholar]
  2. Bryan C. S., Reynolds K. L., Brenner E. R. Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev Infect Dis. 1983 Jul-Aug;5(4):629–638. doi: 10.1093/clinids/5.4.629. [DOI] [PubMed] [Google Scholar]
  3. Carney S. A., Jones R. J. Biological and immunochemical properties of culture filtrates of virulent and avirulent strains of Pseudomonas aeruginosa. Br J Exp Pathol. 1968 Oct;49(5):395–410. [PMC free article] [PubMed] [Google Scholar]
  4. Cryz S. J. Progress in immunization against Klebsiella infections. Eur J Clin Microbiol. 1983 Dec;2(6):523–528. doi: 10.1007/BF02016559. [DOI] [PubMed] [Google Scholar]
  5. Davis B., Lilly H. A., Lowbury E. J. Gram-negative bacilli in burns. J Clin Pathol. 1969 Nov;22(6):634–641. doi: 10.1136/jcp.22.6.634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Domenico P., Johanson W. G., Jr, Straus D. C. Lobar pneumonia in rats produced by clinical isolates of Klebsiella pneumoniae. Infect Immun. 1982 Jul;37(1):327–335. doi: 10.1128/iai.37.1.327-335.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jones R. J., Roe E. A., Gupta J. L. Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients. Lancet. 1980 Dec 13;2(8207):1263–1265. doi: 10.1016/s0140-6736(80)92334-x. [DOI] [PubMed] [Google Scholar]
  8. Jones R. J. Vaccines and antisera against Gram-negative bacilli. J Hosp Infect. 1981 Jun;2(2):105–111. doi: 10.1016/0195-6701(81)90017-7. [DOI] [PubMed] [Google Scholar]
  9. Kreger B. E., Craven D. E., Carling P. C., McCabe W. R. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med. 1980 Mar;68(3):332–343. doi: 10.1016/0002-9343(80)90101-1. [DOI] [PubMed] [Google Scholar]
  10. LIU P. V. FACTORS THAT INFLUENCE TOXIGENICITY OF PSEUDOMONAS AERUGINOSA. J Bacteriol. 1964 Nov;88:1421–1427. doi: 10.1128/jb.88.5.1421-1427.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Montgomerie J. Z. Epidemiology of Klebsiella and hospital-associated infections. Rev Infect Dis. 1979 Sep-Oct;1(5):736–753. doi: 10.1093/clinids/1.5.736. [DOI] [PubMed] [Google Scholar]
  12. Nakashima I., Nagase F., Kato N. Adjuvant action of capsular polysaccharide of Klebsiella pneumoniae on antibody response. VI. Site of its action. Z Immunitatsforsch Immunobiol. 1977 Sep;153(3):204–216. [PubMed] [Google Scholar]
  13. ORSKOV I. Immunological paralysis induced in rabbits by a heavily capsulated Klebsiella strain. Acta Pathol Microbiol Scand. 1956;38(5):375–384. [PubMed] [Google Scholar]
  14. Palfreyman J. M. Klebsiella serotyping by counter-current immunoelectrophoresis. J Hyg (Lond) 1978 Oct;81(2):219–225. doi: 10.1017/s0022172400025043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Riottot M. M., Fournier J. M., Jouin H. Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations. Infect Immun. 1981 Jan;31(1):71–77. doi: 10.1128/iai.31.1.71-77.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Riser E., Noone P. Klebsiella capsular type versus site of isolation. J Clin Pathol. 1981 May;34(5):552–555. doi: 10.1136/jcp.34.5.552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Roe E. A., Jones R. J. Immunization of burned patients against Pseudomonas aeruginosa infection at Safdarjang Hospital, New Delhi. Rev Infect Dis. 1983 Nov-Dec;5 (Suppl 5):S922–S930. doi: 10.1093/clinids/5.supplement_5.s922. [DOI] [PubMed] [Google Scholar]
  18. Smith S. M., Digori J. T., Eng R. H. Epidemiology of Klebsiella antibiotic resistance and serotypes. J Clin Microbiol. 1982 Nov;16(5):868–873. doi: 10.1128/jcm.16.5.868-873.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Thomas F. E., Jackson R. T., Melly A., Alford R. H. Sequential hospitalwide outbreaks of resistant Serratia and Klebsiella infections. Arch Intern Med. 1977 May;137(5):581–584. [PubMed] [Google Scholar]
  20. Williams P., Lambert P. A., Brown M. R., Jones R. J. The role of the O and K antigens in determining the resistance of Klebsiella aerogenes to serum killing and phagocytosis. J Gen Microbiol. 1983 Jul;129(7):2181–2191. doi: 10.1099/00221287-129-7-2181. [DOI] [PubMed] [Google Scholar]
  21. Yokochi T., Nakashima I., Kato N. Further studies on generation of macrophages in in vitro cultures of mouse spleen cells and its inhibition by the capsular polysaccharide of Klebsiella pneumoniae. Microbiol Immunol. 1979;23(6):487–499. doi: 10.1111/j.1348-0421.1979.tb00488.x. [DOI] [PubMed] [Google Scholar]
  22. Ziegler E. J., McCutchan J. A., Fierer J., Glauser M. P., Sadoff J. C., Douglas H., Braude A. I. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med. 1982 Nov 11;307(20):1225–1230. doi: 10.1056/NEJM198211113072001. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Hygiene are provided here courtesy of Cambridge University Press

RESOURCES